CoChat

Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates

Tobias, Peters, Philipp, Seitz Immanuel, Stylianos, Michalakis, Martin, Biel, Barbara, Wilhelm, Felix, Reichel, Alexander, Ochakovski Guy, Eberhart, Zrenner, Marius, Ueffing, Birgit, Korbmacher, Sven, Korte, Ulrich, Bartz-Schmidt Karl, Dominik, Fischer Manuel, the RD-Cure Consortium, Bartz-Schmidt, Karl Ulrich, Bolz, Sylvia, Fischer, Dominik, Kohl, Susanne, Kühlewein, Laura, Mühlfriedel, Regine, Neubauer, Jonas, Ochakovski, Alex, Paquet-Durand, Francois, Seeliger, Mathias, Sothilingam, Vithiyanjali, Ueffing, Marius, Weisschuh, Nicole, Wissinger, Bernd, Zhour, Ahmad, Zobor, Ditta, Zrenner, Eberhart, Biel, Martin, Michalakis, Stylianos, Schön, Christian, Kahle, Nadine, Peters, Tobias, Wilhelm, Barbara, Tsang, Steven, Glöckner, Christian Johannes · 2019 · Human Gene Therapy Clinical Development
Cited by 23

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The purpose of this study was to examine the toxicity and side effects of a recombinant adeno-associated virus 8 (AAV8) vector, aimed to treat cyclic nucleotide gated channel alpha 3 (CNGA3)-linked achromatopsia, after a single subretinal administration in cynomolgus macaques. Animals were followed in two studies: a 13-week study with 22 animals and a 28-day study with 12 animals. Both groups were divided into subgroups receiving either vehicle only, a low (1 × 1011 vector genomes (vg)), or a high dose (1 × 1012 vg) of rAAV.hCNGA3. In the 13-week study, an extra group received single high-dose intravitreal injections. Here we present the group results of the histological examinations carried out after necropsy from the 28-day study, the retinal functional (electroretinography) in the 13-week study, and clinical observations from both studies. Treatment-related adverse effects were not found, and parameter changes were mostly related to the surgical procedure. The treatment of achromatopsia with rAAV.hCNGA3 is therefore deemed safe to apply to humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/humc.2018.188

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 23

Metadata

Authors
Tobias, P., Philipp, S. I., Stylianos, M., Martin, B., Barbara, W., Felix, R., Alexander, O. G., Eberhart, Z., Marius, U., Birgit, K., Sven, K., Ulrich, B.-S. K., Dominik, F. M., the RD-Cure Consortium, Bartz-Schmidt, K. U., Bolz, S., Fischer, D., Kohl, S., Kühlewein, L., Mühlfriedel, R., Neubauer, J., Ochakovski, A., Paquet-Durand, F., Seeliger, M., Sothilingam, V., Ueffing, M., Weisschuh, N., Wissinger, B., Zhour, A., Zobor, D., Zrenner, E., Biel, M., Michalakis, S., Schön, C., Kahle, N., Peters, T., Wilhelm, B., Tsang, S., & Glöckner, C. J.
Venue
Human Gene Therapy Clinical Development
Published
2019-06
Volume
30
Issue
2
Pages
50-56
ISSN
  • 2324-8637 (ISSN-L)
  • 2324-8645
OpenAlex
W2921200169
Cited by
23
References
3
FWCI
0.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.